Yahoo Finance

Voyageur Pharmaceuticals Advances Frances Creek Project, Paving the Way for a Secure, Vertically Integrated Barium Contrast Product Line

CALGARY, ALBERTA - March 4, 2025 (NEWMEDIAWIRE) - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) ("Voyageur" or the "Company") is pleased to announce the commencement of the Frances Creek ...
Seeking Alpha

Voyageur Launches Market Introduction of Barium Contrast Product Line Following Successful Clinical Study Results

Positive feedback received after completion of CDC tests on 24 subjects All key product performance milestones met or exceeded expectations Voyageur believes it is now a player in the contrast media ...
Yahoo Finance

Voyageur Pharmaceuticals Initiates First Commercial Shipments of Barium Contrast Products to Canadian Clinics

CALGARY, ALBERTA - August 21, 2025 (NEWMEDIAWIRE) - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) ("Voyageur" or the "Company"), a radiology contrast media company focused on vertical ...
Seeking Alpha

Voyageur Recaps Significant 2024 Achievements and Unveils Plans for Transformational 2025, Including Market Launch for Barium Suite of Products and Advancement of Iodine Suite

December 20, 2024-The Company announced that it entered into a Letter of Intent agreement with a large multinational pharmaceutical company aiming to gain efficiencies in production of contrast media ...
Monthly Prescribing Reference

First Barium-Based Contrast Agent Gets FDA Approval

Bracco Diagnostics announced that the Food and Drug Administration (FDA) has approved E-Z-HD (barium sulfate) for oral suspension for use in double-contrast radiographic examinations of the esophagus, ...
Stockhouse

Voyageur Commences Testing of Innovative Barium Contrast Product Line in Human Radiology Scans, Paving the Way for Near-Term Market Launch

Calgary, Alberta, Canada – TheNewswire - January 13, 2025 - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) ("Voyageur" or the "Company") is pleased to announce that it has begun human ...
Hosted on MSN

Voyageur Pharmaceuticals is going global: Why it's time to buy the stock

Contrast agents like barium and iodine, which increase the visibility of medical imaging, are suffering from a global shortage, opening the growing US$6.3 billion dollar market up to new players ...
Medscape

Single-Contrast Barium Enema After Unsuccessful Colonoscopy?

Is single-contrast barium enema acceptable management for the patient following unsuccessful colonoscopy? Is air contrast better, or should a repeat colonoscopy be planned? The question posed is ...
Monthly Prescribing Reference

Second Barium-Based Contrast Agent Approved

Bracco Diagnostics announced that the FDA has approved a New Drug Application (NDA) for READI-CAT 2 and READI-CAT 2 SMOOTHIE (barium sulfate) oral suspension for use in computed tomography (CT) of the ...
Nasdaq

Voyageur Pharmaceuticals Announces its “From The Earth To The Bottle” Iodine Contrast Strategy

CALGARY, Alberta, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals Ltd. (TSX.V:VM, USA:VYYRF) (the “Company” or “Voyageur”) is pleased to announce the fully-integrated iodine business ...
Stockhouse

Voyageur Launches Market Introduction of Barium Contrast Product Line Following Successful Clinical Study Results

Calgary, Alberta, Canada – April 23, 2025 – TheNewswire - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) ("Voyageur" or the "Company") a radiology contrast media company focused on vertical ...